Funding Raises: #Parloa $350M Series D; #Rain $250M Series C; #OrcaBio $250M Series F; #AirNexisTherapeutics $200M Series A; #HarmattanAI $200M Series B; #JetZero $175M Series B; #Medipost $140M; #Torq $140M; #DefenseUnicorns $136M Series B; #Deepgram $130M Series C

MEDIPOST Partners with Teikoku Seiyaku for Revolutionary Osteoarthritis Treatment in Japan MEDIPOST has announced a strategic partnership with Teikoku Seiyaku to bring CARTISTEM®, a groundbreaking treatment for knee osteoarthritis, to Japan. This collaboration is set to enhance the availability of innovative therapies for patients in need.

MEDIPOST Partners with Teikoku Seiyaku for Revolutionary Osteoarthritis Treatment in Japan #South_Korea #Seoul #CARTISTEM #MEDIPOST #Teikoku_Seiyaku